Artikel
Öffentlich zugänglich
Frontmatter
Veröffentlicht/Copyright:
11. April 2022
Published Online: 2022-04-11
Published in Print: 2022-04-26
©2022 Walter de Gruyter GmbH, Berlin/Boston
Artikel in diesem Heft
- Frontmatter
- Highlight: Protein Engineering & Design
- Protein engineering & design: hitting new heights
- Antibody display technologies: selecting the cream of the crop
- In vitro evolution of myc-tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-Myc
- Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies
- Trispecific antibodies produced from mAb2 pairs by controlled Fab-arm exchange
- EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
- Modular peptide binders – development of a predictive technology as alternative for reagent antibodies
- Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
- Structural basis of Alzheimer β-amyloid peptide recognition by engineered lipocalin proteins with aggregation-blocking activity
- A guide to designing photocontrol in proteins: methods, strategies and applications
- Atomistic insight into the essential binding event of ACE2-derived peptides to the SARS-CoV-2 spike protein
Artikel in diesem Heft
- Frontmatter
- Highlight: Protein Engineering & Design
- Protein engineering & design: hitting new heights
- Antibody display technologies: selecting the cream of the crop
- In vitro evolution of myc-tag antibodies: in-depth specificity and affinity analysis of Myc1-9E10 and Hyper-Myc
- Prodrug-Activating Chain Exchange (PACE) converts targeted prodrug derivatives to functional bi- or multispecific antibodies
- Trispecific antibodies produced from mAb2 pairs by controlled Fab-arm exchange
- EGFR binding Fc domain-drug conjugates: stable and highly potent cytotoxic molecules mediate selective cell killing
- Modular peptide binders – development of a predictive technology as alternative for reagent antibodies
- Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen
- Structural basis of Alzheimer β-amyloid peptide recognition by engineered lipocalin proteins with aggregation-blocking activity
- A guide to designing photocontrol in proteins: methods, strategies and applications
- Atomistic insight into the essential binding event of ACE2-derived peptides to the SARS-CoV-2 spike protein